Recently, carbonic anhydrase (CA) inhibitors have been proposed as a potential new class of antitumor agents. The aim of this study was to evaluate the antitumor activity of three CA inhibitors, namely acetazolamide (AZ) and two newly synthesized aromatic sulfonamides with high affinity for CA IX, 2-(4-sulfamoylphenyl-amino)-4,6-dichloro-1,3,5-triazine (TR1) and 4-[3-(N,Ndimethylaminopropyl) thioreidophenyl sulfonyl aminoethyl] benzenesulfonamide (GA15), against human tumor cells. The effects of AZ, TR1, and GA15 on cell proliferation and apoptosis were evaluated in CA IXpositive HeLa and 786-O cells and CA IX-negative 786-O/von Hippel-Lindau (VHL) cells. We also investigated whether the potential antitumor activity of these molecules might be mediated by an increase in ceramide production. AZ, TR1, and GA15 could significantly reduce cell proliferation and induce apoptosis in HeLa and 786-O cells. Moreover, all three inhibitors could decrease intracellular pH (pH(i)) and increase ceramide production in the same cells. Treatment with the ceramide synthase inhibitor fumonisin B1 prevented the apoptotic effects of the three CA inhibitors. In all experiments, the effects of aromatic sulfonamides were more pronounced than those of AZ. The three inhibitors did not show any antitumor activity in CA IX-negative 786-O/VHL cells and failed to lower pH(i) or increase intracellular ceramide levels in the same cells. In conclusion, CA inhibition can decrease cell proliferation and induce apoptosis in human tumor cells. The ability of CA inhibitors to decrease pH(i) might trigger cell apoptosis through mediation of ceramide synthesis. Activation of this apoptotic cascade probably is mediated by inhibition of the CA IX isoform. Previous SectionNext Section
Introduction
The carbonic anhydrase (CA) family includes 16 catalytically active zinc metalloenzymes involved in the reversible hydration of carbon dioxide to bicarbonate and a proton (Supuran, 2004) . These isoforms differ mainly in their catalytic activity, tissue distribution, and subcellular localization. Indeed, there are cytosolic, mitochondrial, secreted, and membrane-bound isozymes (Pastorekova et al., 2004) . Among the latter, CA IX and CA XII have been found to be overexpressed in a wide variety of human tumors and involved in A possible targeted approach directed at CA IX would be to inhibit its enzymatic activity with chemical inhibitors (Supuran, 2008) . Recent studies showed that CA inhibitors, such as 
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Materials and Methods
Cell Culture and Drugs. Cell Viability Assay. 
Caspase-3 Activity Determination.
The activity of caspase-3 was determined by using a fluorescent substrate as described 
Statistical Analysis.
Cell viability and proliferation, caspase-3 activity, flow cytometric determination of cell apoptosis and ceramide synthesis, and pHi determination are expressed as means ± S.E.
The differences in these parameters were compared through the paired-value Wilcoxon test or the Mann-Whitney test as appropriate. All the probabilities (P) resulted from two-sided statistical tests; P < 0.05 is considered statistically significant.
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Results
CA IX Expression in Tumor Cells.
We (Fig. 2) . We also confirmed CA IX expression in dense HeLa cell cultures (Fig. 2) in accordance with previously published data (Chrastina, 2003).
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Effects of AZ, TR1, and GA15 on Cell Viability.
Cell viability was determined by the MTT assay. Treatment with AZ, TR1, or GA15 could decrease cell viability in a dose-dependent manner in CA IX-positive HeLa and 786-O cells (Fig. 3, A and B) . AZ significantly inhibited cell viability in the two cell lines at concentrations ≥50 μM, whereas both TR1 and GA15 had significant effects at concentrations ≥25 μM. In CA IX-negative 786-O/VHL cells, administration of AZ, TR1, or GA15 failed to reduce cell viability (Fig. 3C) . 
Effects of AZ, TR1, and GA15 on Cell Proliferation.
Cell proliferation was assessed by both cell count and [ 3 H]thymidine uptake. Tumor cell proliferation was significantly inhibited by AZ, TR1, or GA15 administration in HeLa and 786-O cells (Fig. 4, A-D) . The antiproliferative activity of either TR1 or GA15 was higher than that of AZ (Fig. 4, A-D) . In 786-O/VHL cells, the three inhibitors could not decrease cell proliferation (Fig. 4 , E and F).
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Effects of AZ, TR1, and GA15 on Cell Apoptosis.
We further questioned whether CA inhibitors could influence the apoptotic process in cancer cells. We first evaluated the involvement of these molecules in inducing the early events of the apoptotic process, i.e., caspase-3 activation. AZ and, more efficiently, TR1
and GA15 significantly increased caspase-3 activity in HeLa and 786-O cells (Fig. 5 , A and C). Flow cytometric detection of cell apoptosis confirmed our findings on caspase-3 activation. We found a significant increase in the number of apoptotic cells after treatment with AZ, TR1, and GA15 in HeLa and 786-O cells (Fig. 5, B and D) . Both TR1 and GA15 determined a more pronounced apoptotic effect than did AZ (Fig. 5, A-D) . In 786-O/VHL cells, AZ, TR1, or GA15 administration did not influence apoptotic activity (Fig. 5 , E and F).
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In a new window (Fig. 6, A and B) . The highest effect was obtained by either TR1 or GA15 administration (Fig. 6, A and B) . None of the CA inhibitors tested significantly decreased pHi in 786-O/VHL cells (Fig. 6C ).
Effects of AZ, TR1, and GA15 on Ceramide Production.
Ceramide is a ubiquitous sphingolipid messenger that plays an important role in the control (Fig. 8, A-D) . The apoptotic effect of the three inhibitors was significantly prevented by the administration of the ceramide synthase inhibitor FB1 in the two cell lines (Fig. 7, B and D) . AZ, TR1, and GA15 did not increase ceramide production in 786-O/VHL cells (Figs. 7E and 8, E and F). FB1 administration in the same cells did not have any effect on apoptotic activity after CA inhibitor administration (Fig. 7F ).
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Effects of TR1 on p38 MAPK Activation and NT Production.
p38 MAPK is known as a downstream mediator of ceramide-induced apoptosis (Chen et al., 2008) . We found that treatment of HeLa and 786-O cells with TR1 resulted in a significant increase in the phosphorylation of p38 MAPK (Fig. 9) . TR1 did not influence phosphorylation of p38 MAPK in 786-O/VHL cells (Fig. 9) . It is also known that ceramide stimulates formation of nitro-oxidative species, including peroxynitrite, that can induce cell apoptosis in several pathophysiological conditions (Cuzzocrea et al., 2008) . We found that treatment of HeLa and 786-O cells with TR1 increases cell expression of NT, the stable product of the action of peroxynitrite on tyrosine-containing proteins (Fig. 10, A-D) . No significant effect on NT expression was found in 786-O/VHL cells (Fig. 10, E and F) .
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In a new window In conclusion, our study demonstrates that CA inhibition can decrease cell proliferation and induce apoptosis in cancer cells. One of the most relevant mechanisms potentially involved in this antitumor effect is the ability of CA inhibitors to induce intracellular acidosis by suppressing CA IX activity. Indeed, lowering the pHi might trigger tumor cell apoptosis through activation of ceramide-controlled signaling pathways. These findings point to CA IX inhibition as a useful tool in the clinical management of those human tumors that highly express this enzyme.
